1.
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations
by Aletaha, D
Annals of the rheumatic diseases, 2008-10, Vol.67 (10), p.1360-1364
2.
AB0075 MTOR: An Unexpected Role on the TNF-Regulated MRNA Transcriptome in Rheumatoid Fibroblast-Like Synoviocytes
by Karonitsch, T
Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.915-916
3.
OP0284 Mtor Plays A Decisive Role in the Rheumatoid Mesenchymal Tissue Response to Inflammation
by Karonitsch, T
Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.169-169
4.
FRI0033 Mtor directed mesenchymal tissue response to inflammation in arthritis
by Karonitsch, T
Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A379-A379
5.
A4.6 Nicotinic acetylcholine receptor ligands inhibit osteoclastogenesis by blocking RANKL-induced calcium-oscillation and induction of NFATC1 and CFOS
by Mandl, P
Annals of the rheumatic diseases, 2014-03, Vol.73 (Suppl 1), p.A58-A59
6.
A6.8 Tissue chitchat: wired communication between cells
by Byrne, RA
Annals of the rheumatic diseases, 2015-03, Vol.74 (Suppl 1), p.A58-A58
7.
A6.14 mTOR Directed Mesenchymal Tissue Response to Inflammation in Arthritis
by Karonitsch, T
Annals of the rheumatic diseases, 2013-03, Vol.72 (Suppl 1), p.A47-A47
8.
A1.8 A dual role of MTOR in the rheumatoid mesenchymal tissue response to inflammation
by Karonitsch, T
Annals of the rheumatic diseases, 2014-03, Vol.73 (Suppl 1), p.A3-A4
9.
Sensitisation of the IFN -Stat1-signalling-pathway in rheumatoid arthritis monocytes
by Karonitsch, T.
Annals of the rheumatic diseases, 2011-03-01, Vol.70 (Suppl 2), p.A15-A16
10.
Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients with rheumatoid arthritis
by Karonitsch, T
Annals of the rheumatic diseases, 2008-10, Vol.67 (10), p.1365-1373
11.
IFN-gamma promotes fibroblast-like synoviocytes motility
by Karonitsch, T
Annals of the rheumatic diseases, 2010-03, Vol.69 (Suppl 2), p.A63-A63
12.
A dual role of MTOR in the rheumatoid mesenchymal tissue response to inflammation
by Wanivenhaus, A
Annals of the rheumatic diseases, 2014-03-01, Vol.73 (3), p.A3
13.
Nicotinic acetylcholine receptor ligands inhibit osteoclastogenesis by blocking RANKL-induced calcium-oscillation and induction of NFATC1 and CFOS
by Redlich, K
Annals of the rheumatic diseases, 2014-03-01, Vol.73 (3), p.A58
14.
Mtor plays a decisive role in the rheumatoid mesenchymal tissue response to inflammation
by Karonitsch, T
Annals of the rheumatic diseases, 2014-06-01, Vol.73 (6), p.169
15.
A2.6MTOR plays a decisive role in the mesenchymal tissue response to inflammation in arthritis
by Karonitsch, T
Annals of the rheumatic diseases, 2015-03-01, Vol.74 (Suppl 1), p.A18-A18
16.
A2.6 MTOR plays a decisive role in the mesenchymal tissue response to inflammation in arthritis
by Karonitsch, T
Annals of the rheumatic diseases, 2015-03, Vol.74 (Suppl 1), p.A18-A18
17.
A6.8Tissue chitchat: wired communication between cells
by Byrne, R A
Annals of the rheumatic diseases, 2015-03-01, Vol.74 (Suppl 1), p.A58-A58
18.
Microbes and autoimmunity: mTOR directed mesenchymal tissue response to inflammation in arthritis
by Karonitsch, T
Annals of the rheumatic diseases, 2013-03-01, Vol.72 (3)
19.
IFNγ promotes the invasive behavior of fibroblast-like synoviocytes
by Karonitsch, T
Annals of the rheumatic diseases, 2012-02, Vol.71 (Suppl 1), p.A48-A48
20.
IFN[GAMMA] promotes the invasive behavior of fibroblast-like synoviocytes
by T Karonitsch
Annals of the rheumatic diseases, 2012-02-01, Vol.71, p.A48
